Journal of Pharmaceutical Research (Dec 2021)

Association of Mucormycosis in Covid-19 and its Epidemiologic Study

  • Suchismita Mishra,
  • Saurav Suman,
  • Akshat Gupta,
  • Neelima Mishra

DOI
https://doi.org/10.18579/jopcr/v20i4.MS21073
Journal volume & issue
Vol. 20, no. 4
pp. 88 – 96

Abstract

Read online

Mucormycosis, also known as Zygomycosis or Black Fungus, is an infection caused in humans via various causative agents from the Zygomycetes class. Several countries including India is afflicted by the covid-19 virus, which has infected approximately 3.7 million people across the country. Some of the corona-positive patients suffer from another fatal infection, Mucormycosis, commonly known as Black Fungus. The strategy should be to administer an effective antifungal drug as soon as possible at the optimum dose. However, India being an epicenter of Diabetes with enormous 80 million diabetics, is of particular importance in the present scenario of the COVID pandemic. COVID therapy with Steroids and immune suppressants has increased the chances of infection in various individuals within the country with weaker immune system responses. The main purpose of this paper is to enlighten the community about the involvement of mucormycosis in covid-19 affected population and basic insights of its invasion. Keywords Mucormycosis, Black Fungus, Covid-19, Diabetes Mellitus, Amphotericin B, Immunosuppression, Apophysomyces, Renal Failure, Corticosteroids